Safety and Effectiveness of GP0112 for Cheek Augmentation and Correction of Midface Contour Deficiencies

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
A randomized, evaluator-blinded, parallel group, comparator-controlled, multicenter study to evaluate the safety and effectiveness of GP0112 for cheek augmentation and correction of midface contour deficiencies
Epistemonikos ID: 8be1fa7ee32f98ce949adb527e0eca3caa41eff4
First added on: May 10, 2024